Z-LEHD-fmk Options
The higher distinction from placebo noticed for that IFN-superior sufferers supports the speculation which the peripheral blood IFN test position reflects systemic sort I IFN action. In contrast, for IFN-lower patients there was a more compact variance in reaction prices amongst the placebo and the 200 mg or 1200 mg month-to-month sifalimumab gro